Commentary · 21 Feb 2026
Conference abstractPublished 19 Sep 2016
Claudin-4 as predictor of response to neo-adjuvant chemotherapy in breast cancer
Safdarjung Hospital, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Neo-adjuvant chemotherapy (NACT) is an integral part of multi-modality approach in the management of locally advanced breast cancers (LABC) and is vital to predict response in order to tailor the regimen for a patient. Claudins are important trans-membrane proteins in the inter-cellular tight junctions. Claudin-3, 4 & 7 are often present in breast tumor and are occasionally expressed at elevated levels. A prospective clinical study was conducted to assess whether these markers could serve as reliable predictors of response to NACT in patients with LABC. Materials & Methods: 80 LABC patients after complete routine and metastatic work up were subjected to trucut biopsy and the tissue evaluated, immunohistochemically for claudin-4. Three cycles of NACT were given at three weekly interval & patients were assessed for clinical response following each cycle. Modified radical mastectomy was performed in all patients three weeks after the third cycle and specimen was re-evaluated for any change in the claudin-4 expression. The immunohistochemical response (change in the expression of claudin-4 marker) and the clinical response were correlated. Results: A statistically significant correlation was observed between clinical and immunohistochemical response to NACT. Increase in the expression of claudin-4 indicated poor response to NACT and thus a poor outcome. Conclusions: Claudin-4 can be effectively utilized as predictors of response to NACT.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Mandeep Kaur”
- BylineArticles whose byline prints “Chintamani”
- BylineArticles whose byline prints “Niranjan Kumar”
- BylineArticles whose byline prints “Deepak Diwakar”
- BylineArticles whose byline prints “Manish Kumar Mishra”
- BylineArticles whose byline prints “Ravi Prakash Verma”
- BylineArticles whose byline prints “Anju Bansal”
- BylineArticles whose byline prints “Fouzia”
